Autopsy report · NCT01165619

Detailed Clinical, Biochemical and Genetic Characterization in Gonadotropin-releasing Hormone (GnRH) Deficiency Disorders

“the Principal Investigator left the institution”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month after it had already started.
• Ran for about 4 months before it stopped.
• 50 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Massachusetts General Hospital

Sponsor type

University, hospital or other

Conditions

Idiopathic Hypogonadotropic Hypogonadism; Hypothalamic Amenorrhea

Participants

50

Sites

1

Countries

United States

Trials that died the same way

• Pupillometry Guided Remifentanil Administration In Pediatric Anesthesia
  “Principal investigator left the institution” (98% match in meaning)
• Melphalan on Disease Burden Measured by Next Generation Sequencing Before AHCT (Autologous Hematopoietic Cell Transplant) for Multiple Myeloma
  “The original principal Investigator left the institution.” (97% match in meaning)
• Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM)
  “Original Principal Investigator left the institution.” (96% match in meaning)
• Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM
  “Principal Investigator has left the institution” (96% match in meaning)
• Effect of Virtual Reality Training by Novices on Laparoscopic Cholecystectomy in a Porcine Model
  “Principal investigator left institution.” (94% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.